DE60211149D1 - Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren - Google Patents

Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren

Info

Publication number
DE60211149D1
DE60211149D1 DE60211149T DE60211149T DE60211149D1 DE 60211149 D1 DE60211149 D1 DE 60211149D1 DE 60211149 T DE60211149 T DE 60211149T DE 60211149 T DE60211149 T DE 60211149T DE 60211149 D1 DE60211149 D1 DE 60211149D1
Authority
DE
Germany
Prior art keywords
inhibitors
pyrimidine derivatives
selective cox
cox
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60211149T
Other languages
English (en)
Other versions
DE60211149T2 (de
Inventor
Alan Naylor
John Payne
Anthony Pegg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE60211149D1 publication Critical patent/DE60211149D1/de
Publication of DE60211149T2 publication Critical patent/DE60211149T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DE60211149T 2001-05-25 2002-05-23 Pyrimidinderivate zur verwendung als selektive cox-2 inhibitoren Expired - Lifetime DE60211149T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0112802 2001-05-25
GBGB0112802.4A GB0112802D0 (en) 2001-05-25 2001-05-25 Pyrimidine derivatives
PCT/GB2002/002415 WO2002096885A1 (en) 2001-05-25 2002-05-23 Pyrimidine derivatives useful as selective cox-2 inhibitors

Publications (2)

Publication Number Publication Date
DE60211149D1 true DE60211149D1 (de) 2006-06-08
DE60211149T2 DE60211149T2 (de) 2006-09-07

Family

ID=9915322

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60211149T Expired - Lifetime DE60211149T2 (de) 2001-05-25 2002-05-23 Pyrimidinderivate zur verwendung als selektive cox-2 inhibitoren
DE60229669T Expired - Lifetime DE60229669D1 (de) 2001-05-25 2002-05-23 X-2 inhibitoren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60229669T Expired - Lifetime DE60229669D1 (de) 2001-05-25 2002-05-23 X-2 inhibitoren

Country Status (29)

Country Link
US (2) US7026327B2 (de)
EP (2) EP1390351B1 (de)
JP (1) JP4291688B2 (de)
KR (1) KR100889427B1 (de)
CN (1) CN1255387C (de)
AR (1) AR036028A1 (de)
AT (2) ATE325103T1 (de)
AU (1) AU2002302764B2 (de)
BR (1) BR0209787A (de)
CA (1) CA2448192A1 (de)
CO (1) CO5540311A2 (de)
CZ (1) CZ20033204A3 (de)
DE (2) DE60211149T2 (de)
DK (1) DK1390351T3 (de)
ES (2) ES2316918T3 (de)
GB (1) GB0112802D0 (de)
HK (1) HK1063311A1 (de)
HU (1) HUP0401280A3 (de)
IL (1) IL158799A0 (de)
MX (1) MXPA03010583A (de)
MY (1) MY130750A (de)
NO (1) NO326949B1 (de)
NZ (1) NZ529719A (de)
PL (1) PL366514A1 (de)
PT (1) PT1390351E (de)
SI (1) SI1390351T1 (de)
TW (1) TWI327140B (de)
WO (1) WO2002096885A1 (de)
ZA (1) ZA200308826B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
ATE325115T1 (de) 2002-08-19 2006-06-15 Glaxo Group Ltd Pyrimidinderivate als selektive cox-2-inhibitoren
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
US20070142411A1 (en) * 2003-11-19 2007-06-21 James Hagan Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
EP1687000A2 (de) * 2003-11-19 2006-08-09 Glaxo Group Limited Verwendung von cyclooxygenase-2-hemmern zur behandlung von depressionen
WO2021050700A1 (en) * 2019-09-13 2021-03-18 The Broad Institute, Inc. Cyclooxygenase-2 inhibitors and uses thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149109A (en) * 1962-02-20 1964-09-15 Searle & Co Certain 4-trifluoromethyl-2-(oxy/thio) pyrimidines
GB1121922A (en) * 1966-06-17 1968-07-31 Ici Ltd Pyrimidine derivatives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
ES2193609T3 (es) * 1993-11-30 2003-11-01 Searle & Co Pirazolil-bencenosulfonamidas sustituidas y su uso como inhibidores de la ciclooxigenasa ii.
CN1118454C (zh) 1994-09-09 2003-08-20 日本新药株式会社 杂环衍生物和医药
US5596008A (en) 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
WO1996041645A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6020343A (en) * 1995-10-13 2000-02-01 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
JPH09241161A (ja) 1996-03-08 1997-09-16 Nippon Shinyaku Co Ltd 医 薬
JPH09266197A (ja) * 1996-03-28 1997-10-07 Mitsubishi Electric Corp 半導体装置およびその製造方法
SI0912518T1 (en) 1996-07-18 2003-12-31 Merck Frosst Canada & Co. Substituted pyridines as selective cyclooxygenase-2 inhibitors
TWI235060B (en) 1996-10-15 2005-07-01 Searle & Co Pharmaceutical compositions comprising substituted pyrazolyl benzenesulfonamide derivatives for use in treating or preventing an epithelial cell-derived neoplasia
AR038955A1 (es) 1996-12-05 2005-02-02 Amgen Inc Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
CA2296014A1 (en) 1997-07-03 1999-01-14 Frank W. Hobbs Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
ES2231757T3 (es) * 1997-09-05 2005-05-16 Glaxo Group Limited Composiciones farmaceutica que comprenden derivados de 2,3-diaril-pirazolo (1,5-b) piridazina.
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
DE19909541A1 (de) 1998-03-06 1999-10-14 American Cyanamid Co Herbizide 2-Aryloxy- bzw. 2-Arylthio-6-arylpyrimidine
US6306866B1 (en) * 1998-03-06 2001-10-23 American Cyanamid Company Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
US6313072B1 (en) * 1999-02-18 2001-11-06 American Cyanamid Company Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9927844D0 (en) * 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
GB9930358D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0003224D0 (en) 2000-02-11 2000-04-05 Glaxo Group Ltd Chemical compounds
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
US6756498B2 (en) * 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112803D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
US6861249B1 (en) * 2002-04-09 2005-03-01 David Kent Microbial spray for animal waste

Also Published As

Publication number Publication date
DK1390351T3 (da) 2006-08-07
JP4291688B2 (ja) 2009-07-08
EP1493735B1 (de) 2008-10-29
ES2316918T3 (es) 2009-04-16
CA2448192A1 (en) 2002-12-05
KR20040030629A (ko) 2004-04-09
NO326949B1 (no) 2009-03-16
GB0112802D0 (en) 2001-07-18
KR100889427B1 (ko) 2009-03-23
WO2002096885A1 (en) 2002-12-05
ZA200308826B (en) 2005-02-14
CO5540311A2 (es) 2005-07-29
US20050032821A1 (en) 2005-02-10
NO20035206D0 (no) 2003-11-24
US20050187235A1 (en) 2005-08-25
CZ20033204A3 (en) 2004-03-17
ATE412637T1 (de) 2008-11-15
HUP0401280A3 (en) 2009-06-29
AR036028A1 (es) 2004-08-04
EP1493735A1 (de) 2005-01-05
ES2262809T3 (es) 2006-12-01
DE60211149T2 (de) 2006-09-07
HUP0401280A2 (hu) 2004-12-28
TWI327140B (en) 2010-07-11
NZ529719A (en) 2006-02-24
AU2002302764B2 (en) 2005-12-01
ATE325103T1 (de) 2006-06-15
IL158799A0 (en) 2004-05-12
SI1390351T1 (sl) 2006-10-31
DE60229669D1 (de) 2008-12-11
HK1063311A1 (en) 2004-12-24
CN1255387C (zh) 2006-05-10
CN1537104A (zh) 2004-10-13
JP2005511485A (ja) 2005-04-28
EP1390351B1 (de) 2006-05-03
BR0209787A (pt) 2004-06-01
MY130750A (en) 2007-07-31
PT1390351E (pt) 2006-06-30
PL366514A1 (en) 2005-02-07
MXPA03010583A (es) 2004-03-09
NO20035206L (no) 2003-11-24
US7026327B2 (en) 2006-04-11
EP1390351A1 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
ATE395346T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
ATE404564T1 (de) Diazepinoindolderivate als kinaseinhibitoren
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
ATE323072T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
DK1419152T3 (da) HIV-hæmmende pyrimidin-derivater
NO20033635D0 (no) Pyrimidinderivater for inhibering av celle-formering
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE446093T1 (de) Substituierte chinazolin-derivate als aurora- kinase inhibitoren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60332396D1 (de) PYRAZOLOi3,4-B PYRIDINVERBINDUNGEN UND IHRE VERWENDUNG ALS PHOSPHODIESTERASE INHIBITOREN
DE602004025258D1 (de) Aminotriazol-verbindungen als proteinkinase-hemmer
ATE529421T1 (de) Chinolinderivate als phosphodiesterase-hemmer
DK1487805T3 (da) Pyrimidinderivater
ATE368651T1 (de) Pyridazinon-derivate als gsk-3beta-hemmer
ATE509011T1 (de) Pyrimidinderivate als 11beta-hsd1-inhibitoren
ATE443706T1 (de) Pyrrolotriazinverbindungen als kinaseinhibitoren
ATE400569T1 (de) 4-substituierte 1-aminocyclohexan-derivate zur verwendung als orl1-rezeptor- und mu-opiat- rezeptor-liganden
DE602004022170D1 (de) 2-imino-4-(thio)oxo-5-polycyclovinylazoline zur verwendung als pi3-kinase-inhibtoren
ATE417842T1 (de) Verwendung von trisubstituierten benzopyranonen
PT1401828E (pt) Compostos de n-formil-hidroxilamina como inibidores de pdf
DE602004026905D1 (de) 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
EE200300491A (et) 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
ATE412637T1 (de) Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren
ATE302781T1 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition